ASP Isotopes Inc. (NASDAQ:ASPI – Get Free Report) shares saw an uptick in trading volume on Thursday . 4,158,296 shares were traded during trading, an increase of 197% from the previous session’s volume of 1,401,564 shares.The stock last traded at $8.63 and had previously closed at $7.65.
Wall Street Analysts Forecast Growth
Several equities analysts have recently commented on ASPI shares. Canaccord Genuity Group reaffirmed a “buy” rating and issued a $4.50 target price on shares of ASP Isotopes in a research report on Friday, October 18th. Canaccord Genuity Group began coverage on ASP Isotopes in a report on Friday, October 4th. They issued a “buy” rating and a $4.50 price objective on the stock. Finally, HC Wainwright dropped their target price on ASP Isotopes from $5.50 to $4.50 and set a “buy” rating for the company in a report on Wednesday, August 7th.
Get Our Latest Stock Analysis on ASPI
ASP Isotopes Trading Up 9.9 %
ASP Isotopes (NASDAQ:ASPI – Get Free Report) last posted its quarterly earnings data on Monday, August 19th. The company reported ($0.24) EPS for the quarter. The business had revenue of $1.02 million during the quarter. Research analysts predict that ASP Isotopes Inc. will post -0.24 earnings per share for the current year.
Hedge Funds Weigh In On ASP Isotopes
Several hedge funds and other institutional investors have recently made changes to their positions in the company. Fielder Capital Group LLC bought a new position in ASP Isotopes in the second quarter valued at approximately $55,000. Rhumbline Advisers acquired a new position in shares of ASP Isotopes during the 2nd quarter worth $116,000. HTLF Bank boosted its stake in ASP Isotopes by 197.0% in the second quarter. HTLF Bank now owns 105,538 shares of the company’s stock valued at $323,000 after buying an additional 70,000 shares in the last quarter. Virtu Financial LLC grew its position in ASP Isotopes by 477.0% in the first quarter. Virtu Financial LLC now owns 83,677 shares of the company’s stock valued at $346,000 after acquiring an additional 69,176 shares during the last quarter. Finally, Bank of New York Mellon Corp bought a new position in ASP Isotopes in the second quarter valued at about $381,000. 16.80% of the stock is currently owned by institutional investors and hedge funds.
About ASP Isotopes
ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.
Recommended Stories
- Five stocks we like better than ASP Isotopes
- What Investors Need to Know to Beat the Market
- Gilead’s Stock Surge: What’s Fueling the Momentum?
- Consumer Discretionary Stocks Explained
- Breakout Alert: Qualcomm Just Hit The Rally Button
- Dividend Payout Ratio Calculator
- Mercado Libre Shares Go on Sale: Is Now the Time to Buy?
Receive News & Ratings for ASP Isotopes Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ASP Isotopes and related companies with MarketBeat.com's FREE daily email newsletter.